Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 14/20 | 0.59 |
| ▸ | PPARG | P37231 | 13/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 16/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31674325 | 0.89 | PPARD (0.49) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL17061202 | 0.85 | KDM4C (0.55) | PPARDPPARG | |
| SCHEMBL3003128 | 0.83 | PPARG (0.60) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL9979637 | 0.83 | PPARG (0.60) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL204645 | 0.83 | PPARG (0.60) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL15292428 | 0.82 | FFAR1 (0.69) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL4414880 | 0.82 | PPARG (0.59) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL15299338 | 0.82 | FFAR1 (0.69) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL10011520 | 0.82 | PPARG (0.59) | PPARDPPARGFFAR1PPARA | |
| SCHEMBL15211310 | 0.81 | PPARD (0.64) | PPARDPPARGFFAR1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042760-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY | ACONCAGUA BIO INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12486269-B2 | Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity | ACONCAGUA BIO, INC. (US) | 2025-12-02 | — | — | US | disclosed |
| US-20250257067-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY | ACONCAGUA BIO, INC. | 2025-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12486269-B2 | Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity | IAPP, GIPR, SCTR | PPARD 966/4885PPARG 209/4885FFAR1 107/4885 |
| US-20260042760-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY | NPY1R, CALCRL, SCTR | PPARD 2119/4885PPARG 1026/4885FFAR1 126/4885 |
| US-20250257067-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY | IAPP, GIPR, SCTR | PPARD 966/4885PPARG 209/4885FFAR1 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.